NCT02728063View on ClinicalTrials.gov

Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 11, 2016

Primary Completion Date

April 11, 2018

Study Completion Date

April 11, 2018

Conditions
Diarrhea Predominant Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

Lactibiane Tolerance

probiotics

Trial Locations (1)

44093

CHU-Hôtel-Dieu, Service d'Hépato-gastro-entérologie, Nantes

All Listed Sponsors
lead

PiLeJe

INDUSTRY

NCT02728063 - Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance | Biotech Hunter | Biotech Hunter